The Oregon Health and Science University is leading a new clinical trial, Tofacitinib for Prednisone Dependent Pulmonary Sarcoidosis Patients. The purpose of this study is to learn more about treatment of sarcoidosis in patients who currently require corticosteroids. ...
Scientists are working diligently to find the cause of sarcoidosis, but the answer is still unclear. They have uncovered evidence that suggests certain genetic and environmental factors are involved, but with so many factors coming into play, it is difficult to tell...
Patients are often looking for ways they can contribute to the advancement of research for their disease. Luckily, clinical trials are a great way for patients to get involved in the research process. As of now, clinical trials are the most effective way to obtain new...
Since sarcoidosis is a rare disease, doctors often lack the information they need in order to properly care for sarcoidosis patients. Scientists are working diligently to uncover the cause of sarcoidosis and develop a cure, but in the meantime, options for sarcoidosis...
Back in 2016, FSR began our Sarcoidosis Disease Model program with a Request For Applications for research projects that looked for a viable disease model for sarcoidosis. In the years since, we’ve awarded $1,050,000 towards multiple promising projects through a...
FSR awarded an additional $300,000 towards our Sarcoidosis Disease Model program.This recent award brings FSR’s total investment in finding a viable disease model for sarcoidosis to $1,050,000 to date.A major limiting factor in discovering new insights into the...
The Foundation of Sarcoidosis Research is pleased to announce the awardees for the Small Grant Program 2019 Cycle 1, Dr. Nisha Gilotra and Dr. Wonder Drake. FSR’s Small Grant Program funds various field-initiated proposals in clinical and basic science settings....
May 20th is National Clinical Trials Day. This day is celebrated around the world in May to recognize the day that what is often considered the first randomized clinical trial started aboard a British Naval ship that had been struck with scurvy. The date of this first...
While corticosteroids like prednisone are the most commonly prescribed medications for sarcoidosis, many patients struggle with their side effects. FSR is working hard every day to advance research on new treatments for sarcoidosis that will be more effective with...
In Spring of 2018, FSR awarded $1,000,000 to four Sarcoidosis Fellows to promote early career opportunities in sarcoidosis research and clinical work. Almost a year later, these fellows have had the opportunity to develop specialized skills and gain experience in...